Results for category "Doctors"

Tempus, Eric Lefkofsky, and What He’s Done for Cancer

Eric Lefkofsky is a serial entrepreneur born and raised in the United States. Mr. Lefkofsky went to the University of Michigan, where he earned a bachelor’s degree, then immediately returned for a juris doctorate, a professional degree for practicing law.

While Mr. Eric Lefkofsky has been involved in a number of businesses, he’s currently more deeply involved in his current endeavor, Tempus, than any other thus far. Lefkofsky helped found Tempus just a few years ago, a tech company that’s set to prepare the most expansive library of data about cancer patients – and nothing else except such data from cancer patients – all taken from clinical settings, with a healthy dose of information derived from a research setting, in which molecular data is entered alongside clinical cancer-related information to result in a useful, accessible form of such a combination of data.

Tempus effectively allows physicians to have a better idea of how to treat cancer patients’ symptoms on the surface level, as well as which regimens over long periods of time work best in treating the deadly diseases.

Unfortunately for those stricken by cancer, the disease sometimes returns. According to an analysis conducted by the University of Texas Southwest Medical Center, when reviewing just short of 741,000 people that had been recently diagnosed with some form of cancer – all of which were a part of the Surveillance, Epidemiology, and End Results program at the school’s medical center – the SEER study found that 25 percent of people 65 years and older were likely to experience the disease a second time.

Further – and thankfully for younger generations – only 11 percent of people under the age of 65 who had been recently diagnosed were found to have experienced cancer prior to their most recent diagnosis.

The study also found that, depending on what type of cancer had been diagnosed in the past, the prevalence of prior cancer rates ranged anywhere from 4 to 37 percent. A positive sentiment returned from research done as part of the SEER program is that the total number of cancer survivors is steadily growing.